Clipper for ulcerative colitis

Trinity-Chiesi has launched Clipper (beclometasone), licensed for use in combination with aminosalicylates for mild to moderate ulcerative colitis unresponsive to aminosalicylates alone.

The recommended dose is 5mg daily in the morning for up to four weeks.

Further information: Trinity-Chiesi 0161 4885555

Go to: MIMS drug entry for Clipper

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more